675 results on '"Motiwala, Hanif"'
Search Results
152. A Systematic Review on Alternatives in BCG Refractory Disease
153. What the Literature Says NMIBC—BCG or MMC
154. NMIBC, Low Dose BCG and High-Risk Disease
155. Prognostic Factors in BCG
156. Intermediate and High Risk NMIBC and BCG
157. Adverse Effects in BCG Therapy
158. BCG—Patterns of Administration
159. NMIBC—BCG Strain and Outcomes
160. Literature Related to Hyperthermic MMC
161. NMIBC—Fulguration in Low Risk Disease
162. Recurrence in NMIBC
163. Definitive Treatment in NMIBC
164. NMIBC and Oncological Outcomes from Endoscopic Resection
165. Prognostic Factors for Endoscopic Resection in NMIBC
166. Introduction to Bladder Cancer Type and Therapy
167. A New Technique—En Bloc Resection of Bladder Tumours
168. Statement of Main Findings and Specific Areas of Unmet Needs Arising from Systematic Review on Bladder Cancer Screening
169. Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 5 Impact of Operation on General Health
170. Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 4 Psychological Impact
171. Results—Telephone Interviews with Thematic Analyses
172. Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 2 Age Related Disease
173. The Impact of Bladder Cancer Survivorship
174. A Scoring System for Intravesical Therapy and NMIBC
175. NMIBC—BCG Refractory Disease and Use of Interferon
176. Background on Bladder Cancer
177. Management of Non-Muscle Invasive Bladder Cancer
178. NMIBC—High Grade BCG Refractory Disease
179. A New Technique—En Bloc Resection of Bladder Tumours
180. Prognostic Factors in BCG
181. Systematic Review—Results on Bladder Cancer Management in the Elderly
182. Histological Variants in Bladder Cancer—Sarcomatoid Differentiation
183. Research Summary—A New Model of Care for Patients with Bladder Cancer (MODA)
184. Alternatives to BCG Therapy—MMC
185. Statement of Main Findings and Specific Areas of Unmet Needs Arising from Systematic Review on Bladder Cancer Screening
186. NMIBC—Fulguration in Low Risk Disease
187. NMIBC—BCG Refractory Disease and Use of Interferon
188. A Systematic Review of NMIBC and Intravesical Chemotherapy—Results
189. Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 4 Psychological Impact
190. Health Related Quality of Life Measurements in Bladder Cancer Survivorship
191. Adverse Effects in BCG Therapy
192. Systematic Review Search Results—Bladder Cancer Survivorship and Unmet Need
193. What the Literature Says Re BCG
194. Epidemiology, Risk Factors and Occupational Hazards—A Systematic Review
195. Histological Variants in Bladder Cancer—Small Cell Carcinoma
196. Survivorship Challenges in Non-Muscle Invasive Bladder Cancer
197. Bladder Cancer Screening Systematic Review Conclusion
198. Systematic Review Results on BCG Refractory Disease Management
199. BCG and Elderly Patients
200. Histological Variants in Bladder Cancer—Carcinosarcoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.